Виробництво рекомбінантного пухлинного антигену Україна

• 

  The Advantages of Recombinant Tumor Antigen Production

  It also gives us the ability to safely mass-produce these proteins: since we have the genes, we can theoretically put them into any organism that can make a lot of protein for industrial use in a safe and regulated environment. If we know which genes are being used, then we can confirm that the proteins will be non-toxic to humans and that they will also effectively treat cancer.

  
  

• 

  Harnessing Recombinant Tumor Antigens

  Cancer therapeutic підходи using recombinant tumor antigens One of those ways is through vaccines. In addition, these vaccines are linked to reduced risk for multiple types of cancer. This would be done by training your own body to recognize and kill cancerous cells should they ever enter your system. It is like training your body guards to identify the bad cells and ensures they are stopped before it spreads further.

  
  

• 

  Innovative Techniques for Engineering Recombinant Tumor Antigens to Fight Cancer".

  Команда сценаристів at Yaohan are like those who go to school in the morning and generate a better protein. Every day they are laboring to create new technologies that enhance these proteins that fight cancer. Examples include creating better cancer-fighting proteins for a specific cancer. That way, they become an even stronger killer than before since you have trained them to only attack specific cells. They can encode proteins that can trigger a stronger immune response as well. This will basically mean the body has to work a lot harder to kill any cancer that is there in your body.

  
  

Why choose Yaohai Recombinant Tumor Antigen Manufacturing?

• Налаштування, ефективність і економічність

  Yaohai Bio-Pharma is experienced in the development of microbial-derived biologics. We offer customized RD as well as manufacturing solutions, while making sure that there are no risks. We have worked on diverse modalities such as subunit-based recombinant vaccines, Recombinant Tumor Antigen Manufacturing, cytokines, growth factors, single domain antibodies, enzymes, plasmid DNA, the mRNA, and other. We are experts in a variety of microorganisms, including yeast extracellular and intracellular secretion (yields up to 15g/L) as well as bacteria intracellular soluble and inclusion body (yields as high as 10g/L). We have also developed the BSL-2 fermentation platform to create bacteria-based vaccines. We have a track record of improving production processes, thereby increasing yields and decreasing costs. With a highly efficient technology team, we ensure timely and quality project delivery and bring your products to market faster.

• Надійний ланцюг постачання та виробничі можливості

  Yaohai Bio-Pharma, a top 10 producer of Recombinant Tumor Antigen Manufacturing, specializes in microbial fermentation. We have set up a modern facility with advanced facilities as well as robust RD manufacturing capabilities. Five production lines for drug substances complying with GMP standards for microbial purification and ferment along with two automated fill and finish lines for vials as well as cartridges as well as pre-filled needles are readily available. The available fermentation scales range between 100L and 2000L. Vial filling specifications cover 1ml - 25ml. the pre-filled cartridge or syringe filling specifications are between 1-3ml. The production workshop is cGMP certified and offers the availability of commercial and clinical samples. Our plant produces big molecules that are exported to all over the world.

• Професійні знання та великий досвід

  Yaohai Bio-Pharma is a leading in microbial biologics CDMO. Our main focus has been the production of microbial vaccinations and therapeutics to manage the health of pets, humans and animals. health. We have modern RD and manufacturing technology platforms that cover the entire process, from microbial strain engineering, cell banking, process and method design to commercial and clinical manufacturing, which ensures the success supply of the most cutting-edge solutions. Through the years we have gained vast expertise in using microbial sources. Over 200 projects were successfully completed. In addition, we support our clients in get through regulations, such as those of the US FDA as well as EU EMA. We also help them to navigate Australia TGA and China NMPA. Our expert knowledge and vast experience allow us to quickly respond to market demands and provide Recombinant Tumor Antigen Manufacturing CDMO services.

• Система якості та дотримання глобальних нормативних вимог

  Yaohai BioPharma, a top 10 Microbial CDMO, integrates quality and regulatory matters. We have a quality system that is fully compliant with the current GMP standards, as well as international regulations. Our team of regulatory experts has a deep understanding of world-wide regulatory frameworks. This lets us accelerate biological launches. We are able to guarantee traceable production procedures and high-quality products that conform with regulations from the US FDA, Recombinant Tumor Antigen Manufacturing, Australia TGA, and China NMPA. Yaohai BioPharma has successfully passed an on-site audit conducted of the European Union's Qualified Person (QP) for our GMP quality system and production site. We also have been through the initial certification audits of the ISO9001 Quality Management System and ISO14001 Environmental Management System.

Пов’язані категорії товарів

• Виробництво плазмід AAV
• Аналітичні методи плазмідної ДНК
• Бактеріофаг AP205 VLP Виробництво
• Бактеріофаг Q VLP Виробництво
• Виробництво химерної вакцини VLP
• Виробництво кон'югованих VLP вакцин
• Виробництво ДНК-вакцин
• Ферментація E. coli для виробництва VLP
• Виробництво агоністів GLP-1
• GLP-1 Аналог Виробництво

Не знайшли те, що шукали?
Зв'яжіться з нашими консультантами, щоб отримати більше доступних продуктів.